Hemin Promotes Higher Effectiveness of Aminolevulinic-Photodynamic Therapy (ALA-PDT) in A549 Lung Cancer Cell Line by Interrupting ABCG2 Expression

Overview

Journal Med Sci (Basel)

Specialty General Medicine

Date 2024 Nov 25

PMID 39584916

Authors

Anantya Pustimbara

Rahma Wirdatul Umami

Nurul Muhammad Prakoso

Anna Rozaliyani

Jamal Zaini

Astari Dwiranti

Shun-Ichiro Ogura

Anom Bowolaksono

Affiliations

Soon will be listed here.

Abstract

Background/objectives: Due to concerns about drug resistance and side effects, the discovery of improved drugs for lung cancer has attracted studies to find an effective and safe treatment. Aminolevulinic acid-mediated photodynamic therapy (ALA-PDT) is a cancer treatment with minimal side effects. However, ALA-PDT effectiveness can be hindered by ABCG2 and ABCB1 transporters impeding PpIX accumulation. Combining ALA with other substances can enhance PpIX accumulation. Hemin is a potential substance due to its antitumor properties and may be involved in regulating the ABCG2 and ABCB1 expressions.

Methods: The objective of this report is to analyze the effects of administering a combination of hemin and ALA after 48 h on A549 lung cancer cells by quantifying cell viability, intracellular PpIX, and ROS accumulation, completed by ABCG2 and ABCB1 expressions.

Results: Our data indicate that the combination of hemin and ALA followed by photoirradiation decreased the viability of A549 cells, which was due to increased intracellular PpIX and ROS. The expression of ABCG2 mRNA was significantly decreased after ALA-hemin treatment, while the ABCB1 mRNA expression increased. This result might suggest that ABCG2 plays a greater role than ABCB1 in regulating the PpIX accumulation in A549 lung cancer cells.

Conclusions: The combination of ALA and hemin followed by photoirradiation offers a promising novel treatment for lung cancer, and further evaluations of this therapy are required.

References

Pustimbara A, Li C, Ogura S . Hemin enhances the 5-aminolevulinic acid-photodynamic therapy effect through the changes of cellular iron homeostasis. Photodiagnosis Photodyn Ther. 2024; 48:104253. DOI: 10.1016/j.pdpdt.2024.104253. View

Yoshioka E, Chelakkot V, Licursi M, Rutihinda S, Som J, Derwish L . Enhancement of Cancer-Specific Protoporphyrin IX Fluorescence by Targeting Oncogenic Ras/MEK Pathway. Theranostics. 2018; 8(8):2134-2146. PMC: 5928876. DOI: 10.7150/thno.22641. View

Sunder S, Sharma U, Pokharel S . Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management. Signal Transduct Target Ther. 2023; 8(1):262. PMC: 10326056. DOI: 10.1038/s41392-023-01469-6. View

Xiao X, Chen M, Zhang Y, Li L, Peng Y, Li J . Hemin-incorporating DNA nanozyme enabling catalytic oxygenation and GSH depletion for enhanced photodynamic therapy and synergistic tumor ferroptosis. J Nanobiotechnology. 2022; 20(1):410. PMC: 9479271. DOI: 10.1186/s12951-022-01617-0. View

Lai H, Takahashi K, Nakajima M, Tanaka T, Ogura S . Efficiency of aminolevulinic acid (ALA)-photodynamic therapy based on ALA uptake transporters in a cell density-dependent malignancy model. J Photochem Photobiol B. 2021; 218:112191. DOI: 10.1016/j.jphotobiol.2021.112191. View

Boulanger M, Mitchell C, Zhong J, Hsu M . Financial toxicity in lung cancer. Front Oncol. 2022; 12:1004102. PMC: 9634168. DOI: 10.3389/fonc.2022.1004102. View

Lai H, Tani Y, Sukatta U, Rugthaworn P, Thepyos A, Yamamoto S . Mangostin enhances efficacy of aminolevulinic acid-photodynamic therapy against cancer through inhibition of ABCG2 activity. Photodiagnosis Photodyn Ther. 2023; 44:103798. DOI: 10.1016/j.pdpdt.2023.103798. View

Horinouchi H, Kusumoto M, Yatabe Y, Aokage K, Watanabe S, Ishikura S . Lung Cancer in Japan. J Thorac Oncol. 2022; 17(3):353-361. DOI: 10.1016/j.jtho.2021.11.020. View

Kobuchi H, Moriya K, Ogino T, Fujita H, Inoue K, Shuin T . Mitochondrial localization of ABC transporter ABCG2 and its function in 5-aminolevulinic acid-mediated protoporphyrin IX accumulation. PLoS One. 2012; 7(11):e50082. PMC: 3506543. DOI: 10.1371/journal.pone.0050082. View

10.

Colo G, Schweitzer K, Oresti G, Alonso E, Chavez L, Mascaro M . Proteomic analysis of the effect of hemin in breast cancer. Sci Rep. 2023; 13(1):10091. PMC: 10284804. DOI: 10.1038/s41598-023-35125-4. View

11.

Muller P, Abdel Gaber S, Zimmermann W, Wittig R, Stepp H . ABCG2 influence on the efficiency of photodynamic therapy in glioblastoma cells. J Photochem Photobiol B. 2020; 210:111963. DOI: 10.1016/j.jphotobiol.2020.111963. View

12.

Mohammadpour H, Fekrazad R . Antitumor effect of combined Dkk-3 and 5-ALA mediated photodynamic therapy in breast cancer cell's colony. Photodiagnosis Photodyn Ther. 2016; 14:200-3. DOI: 10.1016/j.pdpdt.2016.04.001. View

13.

Krishnamurthy P, Xie T, Schuetz J . The role of transporters in cellular heme and porphyrin homeostasis. Pharmacol Ther. 2007; 114(3):345-58. DOI: 10.1016/j.pharmthera.2007.02.001. View

14.

Mansi M, Howley R, Chandratre S, Chen B . Inhibition of ABCG2 transporter by lapatinib enhances 5-aminolevulinic acid-mediated protoporphyrin IX fluorescence and photodynamic therapy response in human glioma cell lines. Biochem Pharmacol. 2022; 200:115031. PMC: 10258830. DOI: 10.1016/j.bcp.2022.115031. View

15.

Vesel M, Rapp J, Feller D, Kiss E, Jaromi L, Meggyes M . ABCB1 and ABCG2 drug transporters are differentially expressed in non-small cell lung cancers (NSCLC) and expression is modified by cisplatin treatment via altered Wnt signaling. Respir Res. 2017; 18(1):52. PMC: 5364604. DOI: 10.1186/s12931-017-0537-6. View

16.

Pacioni S, DAlessandris Q, Giannetti S, Pepa G, Offi M, Giordano M . 5-Aminolevulinic Acid (5-ALA)-Induced Protoporphyrin IX Fluorescence by Glioma Cells-A Fluorescence Microscopy Clinical Study. Cancers (Basel). 2022; 14(12). PMC: 9221265. DOI: 10.3390/cancers14122844. View

17.

Pignatelli P, Umme S, DAntonio D, Piattelli A, Curia M . Reactive Oxygen Species Produced by 5-Aminolevulinic Acid Photodynamic Therapy in the Treatment of Cancer. Int J Mol Sci. 2023; 24(10). PMC: 10219295. DOI: 10.3390/ijms24108964. View

18.

Palasuberniam P, Yang X, Kraus D, Jones P, Myers K, Chen B . ABCG2 transporter inhibitor restores the sensitivity of triple negative breast cancer cells to aminolevulinic acid-mediated photodynamic therapy. Sci Rep. 2015; 5:13298. PMC: 4539603. DOI: 10.1038/srep13298. View

19.

Skinner K, Palkar A, Hong A . Genetics of in Cancer. Cancers (Basel). 2023; 15(17). PMC: 10487083. DOI: 10.3390/cancers15174236. View

20.

Kumbham S, Md Mahabubur Rahman K, Bosmajian C, Bist G, Foster B, Woo S . Enhancing PDT efficacy in NMIBC: Efflux inhibitor mediated improvement of PpIX levels and efficacy of the combination of PpIX-PDT and SO-cleavable prodrugs. Photochem Photobiol. 2024; 100(6):1636-1646. PMC: 11568956. DOI: 10.1111/php.13982. View